Skip to content
OmniaBio Full Color Logo

Learn more about our CDMO facilities

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
  • Contact
OmniaBio Full Color Logo

Learn more about our CDMO facilities

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
  • Contact

Cell Therapy CDMO Services

As a technology-focused cell and gene therapy contract development and manufacturing organization (CDMO), OmniaBio specializes in process and analytical development, cell banking, and GMP manufacturing for lentiviral vectors (LVV), induced pluripotent stem cells (iPSCs), and immune cell-based therapies.
CONTACT US

Offering a Continuum of Cell Therapy CDMO Services

Dedicated Support Every Step of the Way

When you choose OmniaBio as your trusted cell therapy CDMO, you choose a collaborative partnership that prioritizes your project’s uniqueness and success.

Leveraging purpose-built infrastructure, specialized capabilities, and years of experience, we offer tailored support so that you can seamlessly transition your therapeutic program from preclinical to commercial stages.

Phase-Appropriate Cell Therapy CDMO Services at Every Stage

From process and analytical development to GMP commercial manufacturing, we support your team at every stage with phase-appropriate services tailored to your therapeutic program needs.

CONTACT US

How Can We Help You Meet Your CMC Milestones?

Process Development

Process development and optimization expertise for enhanced robustness and reliable scale-up.
Explore Process Development

Analytical Development

Comprehensive analytical development services for tailored and established assays.
EXPLORE ANALYTICAL DEVELOPMENT

GMP Manufacturing

Resilient and scalable manufacturing all the way through commercial supply.
EXPLORE GMP MANUFACTURING

Platform Expertise

Cutting-edge cell platforms for lentiviral vector-, immune cell- and iPSC-based therapies.
EXPLORE OUR PLATFORMS

Transforming the Future of Cell Therapy Manufacturing With Purpose-Built Infrastructure

At the forefront of cell and gene therapy manufacturing, our 120,000 ft² Hamilton facility integrates AI models and advanced technologies designed to increase capacity and meet the evolving needs of therapeutic commercialization.

Dedicating 30,000 ft² to GMP manufacturing and operating under stringent quality control, our center of excellence supports OmniaBio’s partners for a smooth transition from early-stage development to commercial stages.

EXPLORE THE FACILITY

Securing Supply Chain Integrity

Located in proximity to Canada’s largest freight airport and less than 40 miles from the U.S. border, OmniaBio’s infrastructure is strategically positioned to provide flexible logistics solutions for seamless worldwide collection and distribution.

Backed by a 24/7 staffing plan, critical cold chain logistics, and real-time tracking system, we designed our supply chain to meet your manufacturing needs and timelines.

Talk to our experts now
OmniaBio Footer Logo in Full Color

© 2025 OmniaBio   |   Privacy Policy

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
Contact Us
Scroll to Top